SlideShare a Scribd company logo
1 of 28
Dr Kamlesh Patel
MBBS MD DCP
Post analytical variables in
diagnostic laboratory
Preanalytical Phase (40- 60 %)
Analytical Phase (7-15 %)
Post-analytical Phase (18-30 %)
● Postanalytical errors occur with entry, manipulation, and reporting
or releasing report or due to improper TAT.
Laboratory testing cycle: 3 Phases
Post analytical phase can be further divided into two phases:
1. Phase inside the laboratory
1. Phase outside the laboratory (post-post-analytical phase):
○ It is not covered in the present recommendations.
○ Refers to procedures in which a physician makes medical
decisions based on laboratory test reports.
Post-analytical can be further divided:
1. Evaluation of test results
2. Decision to release test results
3. Preparation of the laboratory test report
4. Release of the laboratory test report
5. Reporting of test results
6. Sample storage and disposal
7. Archiving of laboratory documentation
8. Post-analytical quality indicators.
Procedures of the post-analytical phase
All test results before release must be evaluated through two mutually
independent activities:
A. Review of test results: This includes
1.1. Comparison with reference intervals
1.2. Comparison with previous results
1.3. Additional procedures
B. Confirmation of test results.
PROCEDURE 1: Evaluation of test results
1.1. Comparison with reference intervals:
Reference intervals or relevant limits according to age and gender have to
be present.(Mandatory)
If reference interval can not be defined it has to indicated in the
“Comments” area.
Reference interval is defined as the central 95% interval bounded by the
2.5th and 97.5th percentiles for a reference population.
PROCEDURE 1: Evaluation of test results
1.2. Comparison with previous results
The testing of the difference between two consecutive results (delta
check) (if previous result available)
Difference between successive results may indicate:
a. A significant change in the patient’s clinical condition, or
b. A problem with the sample.
PROCEDURE 1: Evaluation of test results
1.2. Comparison with previous results
1.2.1. Reference change value(RVC %)
It is useful to assess the significant change in serial results from one
individual using the reference change value (RCV).
It can different for every test. Every lab should define reference change
value in %.
1.2.2. Delta check
PROCEDURE 1: Evaluation of test results
Methods of performing the delta check:
a. Delta difference: Current value – previous value
b. Delta percent change [(Current value – previous value) / previous
value] x100
Delta check is a post-analytical method, every laboratories should define
methods to perform the delta check as well as actions to be taken when
the delta check exceeds the laboratory-specified limits because it can be
very useful to check overall quality of pre analytical and analytical phase.
PROCEDURE 1: Evaluation of test results
Delta check
Recommended actions:
a) Clinical detail: clinical diagnosis, therapeutic interventions, contacting a
physician
b) Retesting the current and previous sample (if available)
c) Checking for the presence of haemolysis, lipemia, icterus, clot
d) Error in tube labelling of the previous and current sample.
PROCEDURE 1: Evaluation of test results
1.3. Additional procedures
1.3.1. Sample dilution
1.3.2. Repeat testing
1.3.3. Communication with a physician/clinical department
1.3.4. Reflex testing: Automated by machine itself as per defined criteria.
1.3.5. Reflective testing: Non-automated procedure in which laboratory
experts add additional tests and/or comments to the original request.
PROCEDURE 1: Evaluation of test results
This decision is made based on all factors that may have influenced the
results, including clinical condition and diagnosis, treatment procedures,
as well as pre-analytical and analytical factors.
2.1. Competences of decision-making laboratory personnel
These personnel must hold master’s degrees in medical biochemistry and
laboratory medicine for the authorisation.
PROCEDURE 2: Decision to release test results
A laboratory test report has to meet the minimum content
requirements:
3.1. Content and layout of the laboratory test report
● Use of recommended, standardised language.
● Presence of all administrative and patient identification data.
● Measurement results and confirmation data.
● Where appropriate, the report should also include comments
necessary for interpretation.
PROCEDURE 3: Preparation of the lab test report
Minimum required content of a laboratory test report
● Administrative data: Detail of the testing laboratory
● Patient identification information* and barcode
● Attributes of measures: Result, reference range, comments,
methods, sample type etc.
● Confirmation of data: Checked by, authorised by etc.
● Comments:
PROCEDURE 3: Preparation of the lab test report
● Electronically or in printed form.
● Electronically released laboratory test reports must be in a “read-only”
format that permits no alterations.
● If releasing laboratory test reports includes sending them
electronically to the patient or the requesting physician via e- mail, the
laboratory must receive signed consent from the patient or physician.
● Results released orally must be documented by the lab.
● The laboratory should record policies and procedures about releasing
reports, including details about who releases reports and to whom.
PROCEDURE 4: Release of the lab test report
Each laboratory must define how it reports test results.
5.1. Reporting of critical results:
● The Lab must have critical limits of laboratory test results. (Define
policy and documentation must)
● Critical results have to be reported within 30 minutes of confirmation.
● Only authorised personnel can report critical results.
PROCEDURE 5: Reporting of test results
PROCEDURE 6: Sample storage and disposal
● The laboratory must have a documented procedure for storing and
safe disposal of biological samples.
● Primary samples must be stored after analyses to ensure their
availability for re-testing or additional testing.
● The laboratory must define durations of storage for biological
samples.
● Optimal storage conditions and duration depend on the type of
sample, analyte stability and analyte half-life.
● Generally, serum or plasma can be stored for 4 hours at room
temperature in primary uncapped tubes, 48 hours at 4 ºC in primary
capped tubes, and several days to several months at - 20 ºC in
secondary capped tubes.
● When a requesting laboratory sends a sample to a referral laboratory, the
shipment should be documented, and an aliquot of the sample should first be
removed and stored at - 20 ºC.
● If an institution archives samples for education, research, or other public
health interests, Must define and document
● Samples must be disposed safely.
PROCEDURE 6: Sample storage and disposal
● Recording and maintenance of medical documentation is a general
(public) duty of health care professionals.
● Archiving of laboratory documentation means storing all important and
meaningful data and notifications in a format that is dated and
certified and can protect the data for a minimum period of time.These
minimum storage periods vary with the type of document.
● the archiving system must protect against documentation loss or
damage.
● If the LIS is linked to the HIS, each employee using the HIS system
should be assigned an account.
PROCEDURE 7: Archiving of lab documentation
The importance of personal data (name, address, email address, IP
address and access point (MAC), global positioning system (GPS)
location, telephone number, video recordings of individuals, identification
number, biometric data (genetic data, educational and professional
information, health data, sexual orientation).
PROCEDURE 7: Archiving of lab documentation
PROCEDURE 8: Post-analytical quality indicators
Minimum recommended quality indicators for the post-analytical phase
are: turnaround time (TAT), percentage of incorrect laboratory test
reports, and notification of critical results.
8.1. Turnaround time
Turnaround time (TAT) is the time interval from the time when the
laboratory receives the sample until the time the test results for that
sample are validated and released.
Monitoring of turnaround time can be expressed in terms of percentage of
tests not performed within a given time.
PROCEDURE 8: Post-analytical quality indicators
8.2. Errors during transcription of results/ incorrect laboratory reports
The percentage all laboratory test reports that are incorrect is another essential
quality indicator in the post-analytical phase
8.3. Notification of critical results
All procedures related to the reporting of critical results have to be recorded and
the data periodically analysed (number or proportion of critical results reported
within a defined period of time).
Methods to minimise the post analytical errors
Adherence to the guidelines and proper staff training may reduce the post
analytical errors.
Take home message
● Post analytical phase is the reflection of Pre analytical and analytical phase.
● Quality starts from the patient himself, patient has to choose right lab or
service before seeking quality.
I am thankful to
Croatian Chamber of Medical Biochemists (CCMB)
Big Thanks to you

More Related Content

What's hot

What's hot (20)

Quality Control In Clinical Laboratory
Quality Control In Clinical LaboratoryQuality Control In Clinical Laboratory
Quality Control In Clinical Laboratory
 
quality control in pathology
quality control in pathologyquality control in pathology
quality control in pathology
 
quality control in clinical pathology
quality control in clinical pathologyquality control in clinical pathology
quality control in clinical pathology
 
Quality control in clinical laboratories
Quality control in clinical laboratoriesQuality control in clinical laboratories
Quality control in clinical laboratories
 
Laboratory Errors
Laboratory ErrorsLaboratory Errors
Laboratory Errors
 
Quality Control in a Medical Testing Laboratory
Quality Control in a Medical Testing LaboratoryQuality Control in a Medical Testing Laboratory
Quality Control in a Medical Testing Laboratory
 
Automation in Clinical Biochemistry.pptx
Automation in Clinical Biochemistry.pptxAutomation in Clinical Biochemistry.pptx
Automation in Clinical Biochemistry.pptx
 
other body fluids pericardial, peritonial,synovial,pleural
other body fluids pericardial, peritonial,synovial,pleural other body fluids pericardial, peritonial,synovial,pleural
other body fluids pericardial, peritonial,synovial,pleural
 
Urine preservative
Urine preservative Urine preservative
Urine preservative
 
Laboratory errors.pdf
Laboratory errors.pdfLaboratory errors.pdf
Laboratory errors.pdf
 
Pre and Post Analytical Errors
Pre and Post Analytical ErrorsPre and Post Analytical Errors
Pre and Post Analytical Errors
 
Quality control in clinical biochemistry
Quality control in clinical biochemistryQuality control in clinical biochemistry
Quality control in clinical biochemistry
 
Quality assurance in a medical laboratory
Quality assurance in a medical laboratoryQuality assurance in a medical laboratory
Quality assurance in a medical laboratory
 
Laboratory Internal Quality Control presentation master revision, 2014
Laboratory Internal Quality Control presentation master revision, 2014Laboratory Internal Quality Control presentation master revision, 2014
Laboratory Internal Quality Control presentation master revision, 2014
 
Quality assurance in haematology
Quality assurance in haematologyQuality assurance in haematology
Quality assurance in haematology
 
Dry chemistry
Dry chemistryDry chemistry
Dry chemistry
 
External Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
External Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...External Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
External Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
 
Automation in Biochemistry (Autoanalyzers)
Automation in Biochemistry (Autoanalyzers)Automation in Biochemistry (Autoanalyzers)
Automation in Biochemistry (Autoanalyzers)
 
Making a 3 5% rbc suspension
Making a 3 5% rbc suspensionMaking a 3 5% rbc suspension
Making a 3 5% rbc suspension
 
Quality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistryQuality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistry
 

Similar to Post analytical variables in Laboratory

Quality control in a virology laboratory.pdf
Quality control in a virology laboratory.pdfQuality control in a virology laboratory.pdf
Quality control in a virology laboratory.pdf
samwel18
 

Similar to Post analytical variables in Laboratory (20)

Post analytical variables dr kamlesh patel
Post analytical variables dr kamlesh patelPost analytical variables dr kamlesh patel
Post analytical variables dr kamlesh patel
 
Quality control in a virology laboratory.pdf
Quality control in a virology laboratory.pdfQuality control in a virology laboratory.pdf
Quality control in a virology laboratory.pdf
 
Quality Control in Pathological Laboratory
Quality Control in Pathological LaboratoryQuality Control in Pathological Laboratory
Quality Control in Pathological Laboratory
 
mlt
mltmlt
mlt
 
iso 15189.pptx
iso 15189.pptxiso 15189.pptx
iso 15189.pptx
 
iso 15189 short.pptx
iso 15189 short.pptxiso 15189 short.pptx
iso 15189 short.pptx
 
Perez.pptx
Perez.pptxPerez.pptx
Perez.pptx
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practices
 
GLP
GLPGLP
GLP
 
good laboratory practices
good laboratory practices good laboratory practices
good laboratory practices
 
Validation of POCT_Rajendra.pptx
Validation of POCT_Rajendra.pptxValidation of POCT_Rajendra.pptx
Validation of POCT_Rajendra.pptx
 
Validation of POCT_Rajendra.pptx
Validation of POCT_Rajendra.pptxValidation of POCT_Rajendra.pptx
Validation of POCT_Rajendra.pptx
 
TAT Analysis.pptx
TAT Analysis.pptxTAT Analysis.pptx
TAT Analysis.pptx
 
White Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care TestingWhite Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care Testing
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White Paper
 
Are we using the correct quality goals?
Are we using the correct quality goals?Are we using the correct quality goals?
Are we using the correct quality goals?
 
Quality control in protozoal identification
Quality control in protozoal identificationQuality control in protozoal identification
Quality control in protozoal identification
 
1 Online-English-Proficiency-Test- 7.28.2020.pptx
1 Online-English-Proficiency-Test- 7.28.2020.pptx1 Online-English-Proficiency-Test- 7.28.2020.pptx
1 Online-English-Proficiency-Test- 7.28.2020.pptx
 
Quality control
Quality controlQuality control
Quality control
 
QMS Seminar.pptx
QMS Seminar.pptxQMS Seminar.pptx
QMS Seminar.pptx
 

More from www.jaailab.com

More from www.jaailab.com (13)

General parasitology
General parasitology General parasitology
General parasitology
 
History and introduction microbiology
History and introduction microbiologyHistory and introduction microbiology
History and introduction microbiology
 
Dr kamlesh patel mmr
Dr kamlesh patel mmrDr kamlesh patel mmr
Dr kamlesh patel mmr
 
Orthomyxovirus: Dr Kamlesh Patel
Orthomyxovirus: Dr Kamlesh PatelOrthomyxovirus: Dr Kamlesh Patel
Orthomyxovirus: Dr Kamlesh Patel
 
Paramyxovirus: Dr Kamlesh Patel
Paramyxovirus: Dr Kamlesh PatelParamyxovirus: Dr Kamlesh Patel
Paramyxovirus: Dr Kamlesh Patel
 
Mycoplasma dr kamlesh patel
Mycoplasma  dr kamlesh patelMycoplasma  dr kamlesh patel
Mycoplasma dr kamlesh patel
 
Rickettsia dr kamlesh patel
Rickettsia  dr kamlesh patelRickettsia  dr kamlesh patel
Rickettsia dr kamlesh patel
 
Urine analysis dr kamlesh patel
Urine analysis   dr kamlesh patelUrine analysis   dr kamlesh patel
Urine analysis dr kamlesh patel
 
Special stain dr kamlesh
Special stain  dr kamleshSpecial stain  dr kamlesh
Special stain dr kamlesh
 
Dr kamlesh patel bone marrow transplantation
Dr kamlesh patel   bone marrow transplantationDr kamlesh patel   bone marrow transplantation
Dr kamlesh patel bone marrow transplantation
 
Miscellaneous bacteria campylo h pylori acineto legionella listeria
Miscellaneous bacteria campylo h pylori acineto legionella listeriaMiscellaneous bacteria campylo h pylori acineto legionella listeria
Miscellaneous bacteria campylo h pylori acineto legionella listeria
 
Semen analysis dr kamlesh
Semen analysis   dr kamleshSemen analysis   dr kamlesh
Semen analysis dr kamlesh
 
Pseudomonas aeruginosa [autosaved]
Pseudomonas aeruginosa [autosaved]Pseudomonas aeruginosa [autosaved]
Pseudomonas aeruginosa [autosaved]
 

Recently uploaded

Recently uploaded (20)

hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFNCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdfรายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRYDEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 

Post analytical variables in Laboratory

  • 1. Dr Kamlesh Patel MBBS MD DCP Post analytical variables in diagnostic laboratory
  • 2. Preanalytical Phase (40- 60 %) Analytical Phase (7-15 %) Post-analytical Phase (18-30 %) ● Postanalytical errors occur with entry, manipulation, and reporting or releasing report or due to improper TAT. Laboratory testing cycle: 3 Phases
  • 3. Post analytical phase can be further divided into two phases: 1. Phase inside the laboratory 1. Phase outside the laboratory (post-post-analytical phase): ○ It is not covered in the present recommendations. ○ Refers to procedures in which a physician makes medical decisions based on laboratory test reports. Post-analytical can be further divided:
  • 4. 1. Evaluation of test results 2. Decision to release test results 3. Preparation of the laboratory test report 4. Release of the laboratory test report 5. Reporting of test results 6. Sample storage and disposal 7. Archiving of laboratory documentation 8. Post-analytical quality indicators. Procedures of the post-analytical phase
  • 5. All test results before release must be evaluated through two mutually independent activities: A. Review of test results: This includes 1.1. Comparison with reference intervals 1.2. Comparison with previous results 1.3. Additional procedures B. Confirmation of test results. PROCEDURE 1: Evaluation of test results
  • 6. 1.1. Comparison with reference intervals: Reference intervals or relevant limits according to age and gender have to be present.(Mandatory) If reference interval can not be defined it has to indicated in the “Comments” area. Reference interval is defined as the central 95% interval bounded by the 2.5th and 97.5th percentiles for a reference population. PROCEDURE 1: Evaluation of test results
  • 7. 1.2. Comparison with previous results The testing of the difference between two consecutive results (delta check) (if previous result available) Difference between successive results may indicate: a. A significant change in the patient’s clinical condition, or b. A problem with the sample. PROCEDURE 1: Evaluation of test results
  • 8. 1.2. Comparison with previous results 1.2.1. Reference change value(RVC %) It is useful to assess the significant change in serial results from one individual using the reference change value (RCV). It can different for every test. Every lab should define reference change value in %. 1.2.2. Delta check PROCEDURE 1: Evaluation of test results
  • 9. Methods of performing the delta check: a. Delta difference: Current value – previous value b. Delta percent change [(Current value – previous value) / previous value] x100 Delta check is a post-analytical method, every laboratories should define methods to perform the delta check as well as actions to be taken when the delta check exceeds the laboratory-specified limits because it can be very useful to check overall quality of pre analytical and analytical phase. PROCEDURE 1: Evaluation of test results
  • 10. Delta check Recommended actions: a) Clinical detail: clinical diagnosis, therapeutic interventions, contacting a physician b) Retesting the current and previous sample (if available) c) Checking for the presence of haemolysis, lipemia, icterus, clot d) Error in tube labelling of the previous and current sample. PROCEDURE 1: Evaluation of test results
  • 11. 1.3. Additional procedures 1.3.1. Sample dilution 1.3.2. Repeat testing 1.3.3. Communication with a physician/clinical department 1.3.4. Reflex testing: Automated by machine itself as per defined criteria. 1.3.5. Reflective testing: Non-automated procedure in which laboratory experts add additional tests and/or comments to the original request. PROCEDURE 1: Evaluation of test results
  • 12. This decision is made based on all factors that may have influenced the results, including clinical condition and diagnosis, treatment procedures, as well as pre-analytical and analytical factors. 2.1. Competences of decision-making laboratory personnel These personnel must hold master’s degrees in medical biochemistry and laboratory medicine for the authorisation. PROCEDURE 2: Decision to release test results
  • 13. A laboratory test report has to meet the minimum content requirements: 3.1. Content and layout of the laboratory test report ● Use of recommended, standardised language. ● Presence of all administrative and patient identification data. ● Measurement results and confirmation data. ● Where appropriate, the report should also include comments necessary for interpretation. PROCEDURE 3: Preparation of the lab test report
  • 14. Minimum required content of a laboratory test report ● Administrative data: Detail of the testing laboratory ● Patient identification information* and barcode ● Attributes of measures: Result, reference range, comments, methods, sample type etc. ● Confirmation of data: Checked by, authorised by etc. ● Comments: PROCEDURE 3: Preparation of the lab test report
  • 15. ● Electronically or in printed form. ● Electronically released laboratory test reports must be in a “read-only” format that permits no alterations. ● If releasing laboratory test reports includes sending them electronically to the patient or the requesting physician via e- mail, the laboratory must receive signed consent from the patient or physician. ● Results released orally must be documented by the lab. ● The laboratory should record policies and procedures about releasing reports, including details about who releases reports and to whom. PROCEDURE 4: Release of the lab test report
  • 16. Each laboratory must define how it reports test results. 5.1. Reporting of critical results: ● The Lab must have critical limits of laboratory test results. (Define policy and documentation must) ● Critical results have to be reported within 30 minutes of confirmation. ● Only authorised personnel can report critical results. PROCEDURE 5: Reporting of test results
  • 17. PROCEDURE 6: Sample storage and disposal ● The laboratory must have a documented procedure for storing and safe disposal of biological samples. ● Primary samples must be stored after analyses to ensure their availability for re-testing or additional testing. ● The laboratory must define durations of storage for biological samples. ● Optimal storage conditions and duration depend on the type of sample, analyte stability and analyte half-life.
  • 18. ● Generally, serum or plasma can be stored for 4 hours at room temperature in primary uncapped tubes, 48 hours at 4 ºC in primary capped tubes, and several days to several months at - 20 ºC in secondary capped tubes. ● When a requesting laboratory sends a sample to a referral laboratory, the shipment should be documented, and an aliquot of the sample should first be removed and stored at - 20 ºC. ● If an institution archives samples for education, research, or other public health interests, Must define and document ● Samples must be disposed safely. PROCEDURE 6: Sample storage and disposal
  • 19.
  • 20. ● Recording and maintenance of medical documentation is a general (public) duty of health care professionals. ● Archiving of laboratory documentation means storing all important and meaningful data and notifications in a format that is dated and certified and can protect the data for a minimum period of time.These minimum storage periods vary with the type of document. ● the archiving system must protect against documentation loss or damage. ● If the LIS is linked to the HIS, each employee using the HIS system should be assigned an account. PROCEDURE 7: Archiving of lab documentation
  • 21. The importance of personal data (name, address, email address, IP address and access point (MAC), global positioning system (GPS) location, telephone number, video recordings of individuals, identification number, biometric data (genetic data, educational and professional information, health data, sexual orientation). PROCEDURE 7: Archiving of lab documentation
  • 22.
  • 23. PROCEDURE 8: Post-analytical quality indicators Minimum recommended quality indicators for the post-analytical phase are: turnaround time (TAT), percentage of incorrect laboratory test reports, and notification of critical results. 8.1. Turnaround time Turnaround time (TAT) is the time interval from the time when the laboratory receives the sample until the time the test results for that sample are validated and released. Monitoring of turnaround time can be expressed in terms of percentage of tests not performed within a given time.
  • 24. PROCEDURE 8: Post-analytical quality indicators 8.2. Errors during transcription of results/ incorrect laboratory reports The percentage all laboratory test reports that are incorrect is another essential quality indicator in the post-analytical phase 8.3. Notification of critical results All procedures related to the reporting of critical results have to be recorded and the data periodically analysed (number or proportion of critical results reported within a defined period of time).
  • 25.
  • 26. Methods to minimise the post analytical errors Adherence to the guidelines and proper staff training may reduce the post analytical errors.
  • 27. Take home message ● Post analytical phase is the reflection of Pre analytical and analytical phase. ● Quality starts from the patient himself, patient has to choose right lab or service before seeking quality. I am thankful to Croatian Chamber of Medical Biochemists (CCMB)